Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

717 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months.
Scherer A, Gwinner W, Mengel M, Kirsch T, Raulf F, Szustakowski JD, Hartmann N, Staedtler F, Engel G, Klupp J, Korn A, Kehren J, Haller H. Scherer A, et al. Among authors: korn a. Nephrol Dial Transplant. 2009 Aug;24(8):2567-75. doi: 10.1093/ndt/gfp183. Epub 2009 Apr 27. Nephrol Dial Transplant. 2009. PMID: 19398767
Basiliximab in pediatric liver transplantation: a pharmacokinetic-derived dosing algorithm.
Kovarik JM, Gridelli BG, Martin S, Rodeck B, Melter M, Dunn SP, Merion RM, Tzakis AG, Alonso E, Bucuvalas J, Sharp H, Gerbeau C, Chodoff L, Korn A, Hall M. Kovarik JM, et al. Among authors: korn a. Pediatr Transplant. 2002 Jun;6(3):224-30. doi: 10.1034/j.1399-3046.2002.01086.x. Pediatr Transplant. 2002. PMID: 12100507 Free article. Clinical Trial.
Safety and efficacy of an alternative basiliximab (Simulect) regimen after renal transplantation: administration of a single 40-mg dose on the first postoperative day in patients receiving triple therapy with azathioprine.
Matl I, Bachleda P, Lao M, Michalský R, Navrátil P, Treska V, Prestele H, Matthisson M, Korn A. Matl I, et al. Among authors: korn a. Transpl Int. 2003 Jan;16(1):45-52. doi: 10.1007/s00147-002-0478-x. Epub 2002 Nov 22. Transpl Int. 2003. PMID: 12545341 Clinical Trial.
Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation.
Lawen JG, Davies EA, Mourad G, Oppenheimer F, Molina MG, Rostaing L, Wilkinson AH, Mulloy LL, Bourbigot BJ, Prestele H, Korn A, Girault D; Simulect International Study Group. Lawen JG, et al. Among authors: korn a. Transplantation. 2003 Jan 15;75(1):37-43. doi: 10.1097/00007890-200301150-00007. Transplantation. 2003. PMID: 12544868 Clinical Trial.
A multicenter, open-label, pharmacokinetic/pharmacodynamic safety, and tolerability study of basiliximab (Simulect) in pediatric de novo renal transplant recipients.
Offner G, Broyer M, Niaudet P, Loirat C, Mentser M, Lemire J, Crocker JF, Cochat P, Clark G, Chodoff L, Korn A, Hall M. Offner G, et al. Among authors: korn a. Transplantation. 2002 Oct 15;74(7):961-6. doi: 10.1097/00007890-200210150-00010. Transplantation. 2002. PMID: 12394837 Clinical Trial.
717 results